Company Profile

Autoimmunity Biologic Solutions Inc
Profile last edited on: 9/8/2023      CAGE: 7ZQN9      UEI: Z41JAMYDRX23

Business Identifier: Novel, personalized therapies for Multiple Sclerosis
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3433 Cove View Boulevard Unit 2504
Galveston, TX 77554
   (787) 420-7613
Location: Single
Congr. District: 14
County: Galveston

Public Profile

Autoimmunity Biologic Solutions, Inc. (aka Autoimmunity BioSolutions and as ABS) is currently developing a combined diagnostic and therapeutic for treatment of multiple sclerosis (MS). ABS is also deploying the firm's therapeutic platform for autoimmune diseases and other diseases (e.g. cancers) that can be addressed by modulation of patients' immune system. The Company's platform technology is based on research conducted at the University of Texas Medical Branch (UTMB), Galveston, TX. The company having received funding from UTMB, with the principals are using their NIH SBIR funding to pursue pre-clinical development of its MS program.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Gaddiel Galarza-Munoz -- Founder, President and CEO

  Thomas Forest Farb-Horch -- Co-founder & Chief Financial Officer

  Gaddiel Galarzamunoz

  Mariano Garcia-Blanco -- Co-founder & Chief Scientific Officer

  Takashi Kiyoizumi

Company News

There are no news available.